Skip to content
Community, Medical Health Aged Care

Accessible healthcare win for Australians affected by mitochondrial disease

NeuRA 2 mins read

For the first time, publicly funded genetic testing is now readily available for Australians who suspect they have mitochondrial disease, enabling them to receive accurate diagnoses and timely treatments.

The Department of Health and Aged Care’s Medical Services Advisory Committee (MSAC) granted approval for whole genome sequencing (genetic testing) in diagnosing primary mitochondrial disease and the changes came into effect this month. 

“This approval marks a turning point, especially for patients and families, many of whom spend decades trying to get a definitive diagnosis of this condition,” says Professor Carolyn Sue AM, an internationally recognised clinician-scientist here at Neuroscience Research Australia and leader in Parkinson’s and mitochondrial disease.

“I’m proud to have led this work with distinguished researchers and professionals in the field of mitochondrial research and advocacy to secure this achievement.”

How will this impact the lives of Australians affected by mitochondrial disease?

In the past, genetic testing for mitochondrial diseases has been a rare and costly option, accessible mainly through research funding, or presenting families with substantial out-of-pocket expenses, often amounting to over $4,000. But this is no longer the case as starting from this month, the test is now covered by Medicare. 

“Publicly funded genetic testing means patients no longer have to face years of uncertainty, seeing an average of 5 – 8 doctors before receiving a diagnosis. Now a simple blood test will enable individuals to get a diagnosis,” says Professor Sue.

“Accessible genetic screening will also shorten diagnosis time for individuals and help them make informed decisions about family planning.

“This will allow them to consider reproductive options like mitochondrial donation through IVF to prevent transmitting the disease to their biological children.

“Importantly, all patients, regardless of their age or life circumstances, will be able to get the right treatments promptly, preventing disease progression and avoiding potentially harmful treatments, a common risk due to the variable nature of mitochondrial disease symptoms.”

A decade dedicated to advocacy

Securing genetic testing for mitochondrial diseases was an achievement that is the result of a decade-long collaborative effort between researchers and mitochondrial advocates.

Involved in the submission process were Professor Carolyn Sue AM, Kinghorn Chair, Neurodegeneration at Neuroscience Research Australia, alongside the Mito Medical Network and researchers from the Centre for Economic Impacts of Genomic Medicine at Macquarie University, and The Children’s Hospital at Westmead.

What is mitochondrial disease?

Mitochondrial diseases, often described as conditions that ​“rob the body of energy,” stem from genetic variations affecting the mitochondria’s ability to create energy. 

Genetic variants that can cause mitochondrial disease are surprisingly common, impacting approximately one in 200 people in Australia. The symptoms of mitochondrial disease are diverse, ranging from extreme fatigue and strokes to seizures, diabetes, and severe hearing loss. 


Key Facts:

Professor Carolyn Sue is available for media interviews.

Previous example of an interview available here: https://www.youtube.com/watch?v=6j_1j3epoDk 


About us:

About NeuRA:
From advances in dementia and mental health to discoveries in chronic pain and falls prevention, Neuroscience Research Australia (NeuRA) has been at the forefront of neuroscience for over 30 years. We are an independent, not-for-profit, medical research institute dedicated to improving the lives of people living with brain and nervous system disorders.


Contact details:

Nadia Razzhigaeva

Senior Communications & PR Officer

0452 140 477

[email protected]

Media

More from this category

  • Medical Health Aged Care
  • 15/06/2025
  • 07:46
Royal Australian College of GPs

Men’s Health Week: Funding for longer consults can make GPs one-stop shop for sexual health and HIV prevention

During Men’s Health Week 2025 the Royal Australian College of GPs (RACGP) is calling on the Federal Government to improve men’s sexual health by boosting investment in general practice care so specialist GPs can provide longer consultations. The College says more funding for longer consultations would improve access to important preventive care, such as pre-exposure prophylaxis (PrEP), – a highly effective daily or on-demand medication that prevents HIV transmission in 99% of cases. RACGP Specific Interests Sexual Health Medicine Chair Dr Sara Whitburn said practices can offer the most convenient access to PrEP for people at higher risk of HIV,…

  • Contains:
  • Medical Health Aged Care
  • 15/06/2025
  • 07:20
Royal Australian College of GPs

GPs ready to support ACT to act on ADHD election commitment

The Royal Australian College of GPs (RACGP) has welcomed work in the ACT to allow GPs to diagnose and prescribe for ADHD. ACT Labor committed to allowing GPs to diagnose ADHD in the 2024 election that returned the party to government for the seventh time. Since that election, the WA Government has committed to improving access for patients by supporting specialist GPs to diagnose and treat ADHD following long-term advocacy by the RACGP and Western Australian GPs. The NSW Government also announced changes to improve access and affordability through treatment by GPs in May. Patients in NSW are expected to…

  • Contains:
  • Medical Health Aged Care
  • 13/06/2025
  • 15:49
The Australian College of Nursing

National Immunisation Strategy backs new ways of vaccine delivery

The Australian College of Nursing is calling for swift regulatory and funding reform to enable more nurses and midwives to provide vaccination independently in more settings for more Australians to increase Australia’s immunisation rates. Acting ACN CEO, Dr Zach Byfield, said the latest National Immunisation Strategy has prioritised ‘the delivery of vaccines in innovative ways’. “Nurses are leaders in innovation and can deliver vaccinations in innovative ways,” Dr Byfield said. “Nurses lead and run vaccination in school-based immunisation settings across the nation. Further, the nursing profession stepped up and led the way exceptionally throughout the Covid pandemic. “But childhood immunisation…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.